TNXP READ THE FULL TNXP RESEARCH REPORT Financial Update On July 25, 2025, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ...

Zou and his team equipped the virtual scientists with tools and software systems, such as the protein modeling AI system ...

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs.Modeled after a well-established Stanford ...

Understanding these glycosylation patterns is just as important as analyzing other tools like labeled peptides, which are ...

DelveInsight's CD40/CD40L Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...

Circular dichroism and fluorescence were used to create a platform for monitoring changes in monoclonal antibodies.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

The aggregation of protein therapeutics such as antibodies remains a major challenge in the biopharmaceutical industry. The present study aimed to characterize the impact of the protein concentration ...

A computational pipeline for improving antibody-antigen binding affinity through CDR-focused mutations, using AI-based inverse folding (ProteinMPNN), structural modeling (IgFold, AlphaFold-Multimer), ...